Finny logo
Dibs:
Dibs:
0

BIB vs UBIO

Both BIB and UBIO are ETFs. Below is the comparison between BIB and UBIO.

BIB UBIO
Security Type ETF ETF
Segment Leveraged Equity: U.S. Biotech Leveraged Equity: U.S. Biotech
Family ProShares ProShares
Net Assets $283.20M N/A
Expense Ratio 0.95% N/A
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.00% 0.00%
Underlying Index NASDAQ Biotechnology Index NASDAQ Biotechnology Index
YTD Return 11.23% -45.67%
1-Year Return 52.64% -39.33%
3-Year Return 18.74% -13.73%
5-Year Return 17.85% 0.00%
10-Year Return 26.64% 0.00%

BIB description

The Fund seeks daily investment results, before fees and expenses, that correspond to two times the return of the Nasdaq Biotechnology Index. The Index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical.

BIB performance & returns

YTD Return 11.23%
1-Month Return 19.55%
3-Month Return 6.65%
1-Year Return 52.64%
3-Year Return 18.74%
5-Year Return 17.85%
10-Year Return 26.64%
BIB expense ratio is 0.95%.

BIB holdings

Top 10 Holdings (128.41% of Total Assets)

Name Symbol % Assets
Nasdaq Biotechnology Index Swap Bank Of America Na N/A 25.20%
Ishares Biotech (Ibb) Swap Goldman Sachs International N/A 19.46%
Nasdaq Biotechnology Index Swap Societe Generale N/A 18.42%
Nasdaq Biotechnology Index Swap Ubs Ag N/A 17.59%
Ishares Biotech (Ibb) Swap Bank Of America Na N/A 12.00%
Nasdaq Biotechnology Index Swap Citibank Na N/A 9.98%
Nasdaq Biotechnology Index Swap Credit Suisse International N/A 9.07%
Nasdaq Biotechnology Index Swap Goldman Sachs International N/A 5.86%
Gilead Sciences Inc GILD 5.46%
Amgen Inc AMGN 5.37%

Other relevant BIB comparisons

You may also want to check out the following BIB comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

UBIO description

UBIO performance & returns

YTD Return -45.67%
1-Month Return -33.54%
3-Month Return -45.67%
1-Year Return -39.33%
3-Year Return -13.73%
5-Year Return 0.00%
10-Year Return 0.00%
UBIO expense ratio is N/A.

UBIO holdings

Top 10 Holdings (241.96% of Total Assets)

Name Symbol % Assets
Nasdaq Biotechnology Index Swap Ubs Ag N/A 75.41%
Nasdaq Biotechnology Index Swap Bank Of America Na N/A 52.94%
Nasdaq Biotechnology Index Swap Goldman Sachs International N/A 38.60%
Nasdaq Biotechnology Index Swap Societe Generale N/A 31.75%
Nasdaq Biotechnology Index Swap Citibank Na N/A 11.72%
Gilead Sciences Inc GILD 7.77%
Vertex Pharmaceuticals Inc VRTX 6.52%
Amgen Inc AMGN 6.41%
Biogen Inc BIIB 6.30%
Regeneron Pharmaceuticals Inc REGN 4.54%

Other relevant UBIO comparisons

You may also want to check out the following UBIO comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
Follow Us